Hexima Limited Share Price

Equities

HXL

AU0000111932

Biotechnology & Medical Research

Market Closed - Australian S.E. 07:10:10 22/04/2024 BST 5-day change 1st Jan Change
0.013 AUD 0.00% Intraday chart for Hexima Limited 0.00% -27.78%

Financials

Sales 2022 5.81M 3.8M 304M Sales 2023 1.48M 970K 77.64M Capitalization 3.51M 2.29M 183M
Net income 2022 -10M -6.53M -523M Net income 2023 -1M -653K -52.29M EV / Sales 2022 0.18 x
Net cash position 2022 3.96M 2.58M 207M Net cash position 2023 2.19M 1.43M 114M EV / Sales 2023 0.89 x
P/E ratio 2022
-0.46 x
P/E ratio 2023
-1.83 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 36.17%
More Fundamentals * Assessed data
Dynamic Chart
Current month+8.33%
1 month+8.33%
3 months-27.78%
6 months-40.91%
Current year-27.78%
More quotes
1 week
0.01
Extreme 0.013
0.01
1 month
0.01
Extreme 0.01
0.01
Current year
0.01
Extreme 0.01
0.02
1 year
0.01
Extreme 0.01
0.02
3 years
0.01
Extreme 0.009
0.50
5 years
0.01
Extreme 0.009
0.50
10 years
0.01
Extreme 0.009
0.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 69 04/09/23
Corporate Secretary - 05/10/21
Members of the board TitleAgeSince
Chief Executive Officer 69 04/09/23
Director/Board Member 64 17/09/23
Director/Board Member - 16/07/18
More insiders
Date Price Change Volume
22/04/24 0.013 0.00% 761,801

Delayed Quote Australian S.E., April 22, 2024 at 07:10 am

More quotes
Hexima Limited is an Australia-based company. The Company is exploring opportunities for transactions with third parties which could enable the potential value of the Company’s assets, including its intellectual property and other intangible assets, to be realized.
More about the company

Annual profits - Rate of surprise